Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. Company
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  12:30:21 2023-03-24 pm EDT
0.0120 CHF   +9.09%
03/13Igea Pharma N : Convening notice & Agenda
PU
2022Igea Pharma N : appoints new Chief Financial Officer
PU
2022Igea Pharma N : Minutes of the AGM 1 December 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Business Summary
IGEA Pharma NV is a biopharmaceutical company based in the Netherlands. The Company focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The Company develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the AlzheimerÔÇÖs disease. The Company offers its services in the Netherlands.
Managers
Name Title Age Since
Vicenzo Moccia Chairman-Management Board 62 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 334,472,250 147,330,632 44.0% 0 0.0% 44.0%
Shareholders
NameEquities%
Pharma Tech Holding SA 101,944,500 30.2%
Pierpaolo Cerani 30,365,010 9.01%
Cristina Canepa 15,500,000 4.60%
Olivetree Foundation 748,958 0.22%
WBS HŘnicke Verm÷gensverwaltung GmbH 400,000 0.12%
Chart AG 48,766 0.014%
Company contact information
IGEA Pharma NV
Siriusdreef 17
Hoofddorp, Noord-Holland 2132 WT

Phone : +31.23.568.94.94
Web : http://www.igeapharma.nl
Brand Portfolio
In partnership withAllbrands.markets
More brands of IGEA Pharma N.V.
Stock markets for all
100% Free Registration
fermer